WHO ICTRP trial
Expressie van CCL25 en CCR9 bij inflammatoire darmziekten en primaire…
NL-OMON26243 · Overview of Medical Research in the Netherlands (NL-OMON) · Recruiting
Key facts
| Trial ID | NL-OMON26243 |
|---|---|
| Public title | Expressie van CCL25 en CCR9 bij inflammatoire darmziekten en primaire scleroserende cholangitis. |
| Scientific title | Expression of CCL25 and CCR9 in human colon in IBD/PSC patients. |
| Primary sponsor | C.IJ. Ponsioen, MD PhD Dept. Gastroenterology and Hepatology Academic Medical Center Amsterdam PO Box 22660 1100 DD Amsterdam The Netherlands [email protected] |
| Registry | Overview of Medical Research in the Netherlands (NL-OMON) |
| Recruitment status | Recruiting |
| Study type | Observational non invasive |
| Conditions | primary sclerosing cholangitis inflammatory bowel disease ulcerative colitis Crohn's disease primaire scleroserende cholangitis inflammatoire darmziekten colitis ulcerosa ziekte van Crohn |
| Interventions | Ileal and colonic biopsies during colonoscopy. |
| Registration date | Apr 13, 2011 |
| Target size | 80 |
| Secondary IDs | NL2713;NTR2851;METC AMC : MEC 09/059;ISRCTN wordt niet meer aangevraagd. |
| Registry page | onderzoekmetmensen.nl |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: